Expert Perspectives on Managing Atrial Fibrillation: Now and into the Future
Saturday, March 29, 2008
12:00 p.m. - 4:00 p.m.
Registration is FREE to all ACC attendees!
On-site registration opens at 11:00 a.m. CDT outside of Room S401, McCormick Place, Chicago, IL
Room S401
McCormick Place
Chicago, IL
Faculty
Co-Chairs
Eric N. Prystowsky, MD, FHRS
Jonathan Halperin, MD, FACC
Program Description
Test your understanding of current clinical guidelines and the consensus of experts for managing patients with atrial fibrillation (AF). This high-powered, interactive symposium will feature the ample use of an audience response system to field pre- and post-tests as well as case-based audience challenges to help participants gauge their knowledge of the most current guidelines and areas of consensus in AF. Topics to be covered include the appropriate use of antiarrhythmic drug therapies, rate and rhythm control, and cardioversion as well as the latest consensus surrounding catheter and surgical ablation. Participants will benefit from first-rate knowledge of the guidelines and synopses of cutting edge developments offered in a series of state-of-the-art lectures by the world’s leading experts in atrial fibrillation.
Objectives
- Discuss AF management strategies for specific patient populations based on the ACC/AHA/ESC Guidelines
- Associate patients with algorithm categories and discriminate the appropriateness of pharmacologic and nonpharmacologic options for the management of AF
- Identify and employ CHADS2 risk scores in making management decisions for AF patients
- Recognize the different methods of cardioversion as well as both pre- and post-procedure anticoagulation strategies and antiarrhythmic drug management
- Recognize the indications for catheter and surgical ablation
- Identify appropriate candidates for ablation
Program Schedule
Saturday, March 29, 2008
12:00 p.m. Introductory Remarks and Pre-test Instructions
12:05 p.m. Pre-test using Audience Response
12:30 p.m. State-of the-Art Mini-Lectures
- Chronic Issues and Controversies in Anticoagulation — Jonathan Halperin, MD
- Recommendations for Cardioversion of Atrial Fibrillation — Eric N. Prystowsky, MD
- Antiarrhythmic Drugs: When Sinus Rhythm Is Necessary — Peter Kowey, MD
- Current Perspectives for Ablation to Treat Atrial Fibrillation — Hugh Calkins, MD
1:40 p.m. Discussion of Pre-test Results
2:00 p.m. Mid-Program Break
2:20 p.m. Interactive Case Challenge
3:30 p.m. Post-test using Audience Response
3:55 p.m. Closing Remarks
4:00 p.m. Adjourn
Accreditation
The Heart Rhythm Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Continuing Medical Education (CME)
The Heart Rhythm Society designates this educational activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The AMA has determined that physicians not licensed in the USA who participate in this CME activity are eligible for AMA PRA Category 1 Credits™
Continuing Education (CE) for Nurses
The Heart Rhythm Society is an approved provider of continuing nursing education by the New York State Nurses Association, which is accredited as an approver of continuing nursing education by the American Nurses Credentialing Center’s Commission of Accreditation.
It has been assigned code 6GDPMX-PRV-061. A maximum of 4 contact hours are available for this educational activity.
